Findings from the trial showed that a significantly greater proportion of patients treated with dupilumab met the primary endpoint achieving significant histological disease remission.
Findings from the trial showed that a significantly greater proportion of patients treated with dupilumab met the primary endpoint achieving significant histological disease remission.
FDA approves dupilumab for children with eosinophilic esophagitis healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.